Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc.（PLSH）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PLSH · 截至 2026年6月15日
活动摘要
买入笔数
17
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Panacea Life Sciences Holdings, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月15日
PLSH 季度内部人买卖趋势
PLSH 内幕交易卖出 · PLSH 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 15, 2026
近期内幕交易记录
PLSH 高管卖出股份 · PLSH 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Sep 18, 2023 | Buttorff Leslie CEO · Director | Purchase | 20,000 | $5K | Form 4 |
| Jun 9, 2023 | Buttorff Leslie CEO · Director | Purchase | 3,000 | $1K | Form 4 |
| Jun 2, 2023 | Buttorff Leslie CEO · Director | Award | 760,000 | $380K | Form 4 |
| May 23, 2023 | Buttorff Leslie CEO · Director | Purchase | 500 | $249 | Form 4 |
| May 19, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,500 | $780 | Form 4 |
| May 19, 2023 | Buttorff Leslie CEO · Director | Purchase | 4,500 | $2K | Form 4 |
| May 9, 2023 | Buttorff Leslie CEO · Director | Purchase | 2,300 | $867 | Form 4 |
| May 8, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,500 | $645 | Form 4 |
| May 5, 2023 | Buttorff Leslie CEO · Director | Purchase | 11,500 | $6K | Form 4 |
| Apr 26, 2023 | Buttorff Leslie CEO · Director | Purchase | 5,500 | $2K | Form 4 |
| Apr 25, 2023 | Buttorff Leslie CEO · Director | Purchase | 3,500 | $1K | Form 4 |
| Apr 25, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $320 | Form 4 |
| Apr 5, 2023 | Buttorff Leslie CEO · Director | Purchase | 2,500 | $825 | Form 4 |
| Apr 4, 2023 | Buttorff Leslie CEO · Director | Purchase | 3,200 | $1K | Form 4 |
| Apr 3, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $360 | Form 4 |
| Feb 27, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $190 | Form 4 |
| Feb 27, 2023 | Buttorff Leslie CEO · Director | Purchase | 2,000 | $345 | Form 4 |
| Feb 26, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $190 | Form 4 |
| Aug 26, 2022 | Buttorff Leslie CEO | Purchase | 11,500 | $2K | Form 4 |
| Aug 11, 2022 | Wert Lawrence Director | Purchase | 5,000 | $640 | Form 4 |
| Aug 3, 2022 | Buttorff Leslie CEO | Purchase | 2,600 | $260 | Form 4 |
| Jul 8, 2022 | Buttorff Leslie CEO | Purchase | 2,100 | $836 | Form 4 |
| Apr 4, 2022 | Buttorff Leslie CEO | Purchase | 1,404 | $842 | Form 4 |
| Jun 30, 2021 | Berman Nathan Joel CONTROLLER & PRIN ACTNG OFCR | Award | 496,957 | — | Form 4 |
| Jun 30, 2021 | Buttorff Leslie CHIEF EXECUTIVE OFFICER · Director | Award | 318,317,499 | — | Form 4 |
Buttorff Leslie
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 30
股数
318,317,499
均价
—
总金额
—
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PLSH 内幕交易
PLSH 内幕交易
Panacea Life Sciences Holdings, Inc.（PLSH）内幕交易数据来源于公司内部人（包括PLSH）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。PLSH内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Panacea Life Sciences Holdings, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PLSH 内幕交易 · 5个问题Panacea Life Sciences Holdings, Inc.（PLSH）的内部人包括高管和董事，如PLSH等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 15, 2026